Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
Status:
Terminated
Trial end date:
2017-11-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety and tolerability of PF-06649751
in Parkinson's disease patients who experience motor-fluctuations.